Enrichment of two rare SNPs among ABC DLBCL tumors.

Slides:



Advertisements
Similar presentations
FINAL EXAM: TAKE-HOME Assessment of Significance in Cancer Gene SNPs.
Advertisements

EBV-positive diffuse large B-cell lymphoma of the elderly by Chi Young Ok, Thomas G. Papathomas, L. Jeffrey Medeiros, and Ken H. Young Blood Volume 122(3):
Homozygous deletions within chromosome 9q23.
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
The cBio Cancer Genomics Portal.
Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.
Regional lymph nodes and distal extracranial metastases are not a reliable surrogate for actionable mutation in brain metastases. Regional lymph nodes.
Enrichment of sequence disorder in the cytosolic phosphoproteome.
AZD9291 binding mode and structure.
Key amino acid positions identified by association analysis are highlighted in three-dimensional ribbon models for the HLA-DR, HLA-DQ, HLA-A and HLA-DP.
Five independent associations were identified after stepwise association analysis within the MHC region at the discovery stage. Five independent associations.
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing  Sylvain Mareschal, Anne.
Multiple sequence alignment and analysis of SOFL proteins.
Genomic alterations in breast cancer cell line MDA-MB-231.
Diagnostic approaches to measure the impact of cancer therapies on clonal evolution. Diagnostic approaches to measure the impact of cancer therapies on.
Copy-number alterations in an archival breast cancer sample.
Potential clinical actionability.
Antigen-specific TCRβ clonotypes map to the TCRβ repertoire at markedly different frequencies. Antigen-specific TCRβ clonotypes map to the TCRβ repertoire.
Identification of a MEK2 mutation in a melanoma sample resistant to dabrafenib/trametinib. Identification of a MEK2 mutation in a melanoma sample resistant.
Distribution of intrinsic subtypes among TNBC and distribution of TNBC among basal-like breast cancer. Distribution of intrinsic subtypes among TNBC and.
Whole-exome sequencing identifies NF1 mutations in tumors of melanoma patients exhibiting resistance to vemurafenib. Whole-exome sequencing identifies.
Properties of proteins and residues with frequent hotspot mutations
Epitope Mapping Performance using a single peptide microarray.
Altered pathways in prostate cancer.
Distribution of informative SNPs with LOH (black bars) on each chromosome (rows, oriented p-arm at the bottom and q-arm at the top of each chromosome)
Nonsense and missense amino acid mutation analysis.
Cancer mutations in enriched RBP motifs.
Alignment of the deduced amino acid sequences of the myosin light chain 2 (MLC2) proteins. Alignment of the deduced amino acid sequences of the myosin.
Comparison of the sequences of Fzo/Mfn and structure of mammalian Mfn2

A 69-year-old man with low-grade lymphoma of the parotid gland
BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.
Frequent alterations identified and potential actionability.
IL6 mRNA is not detected in metastatic prostate cancer cells.
KIT mutations in GISTs. A, amino acid sequence of KIT exon 11 mutations in clinical GIST biopsies. –, amino acids that are deleted; italicized amino acids,
M-Wnt and E-Wnt cells cluster tightly with claudin-low and basal-like breast tumors, respectively, by microarray analysis. M-Wnt and E-Wnt cells cluster.
Gain-of-function conferred by RNF31 SNPs
Modeling of EGFR exon 20 insertions using the 3-dimensional structure of the EGFR kinase domain predicts different interactions with the erlotinib-binding.
Transcripts enriched and depleted in NB TICs compared with SKPs and other tumor tissues. Transcripts enriched and depleted in NB TICs compared with SKPs.
Tumor and serum levels of murine IL-12.
Targetable alterations and pathways in TNBCs after NAC
Comparison of the frequency of nucleotide variation in the mtDNA D-loop region between stomach and other tumor cell lines. Comparison of the frequency.
A, structure of the deduced polypeptides coded by MAGE-E1 mRNAs.
Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.
Association between BRCA1 transcript level and cisplatin sensitivity, BRCA1 promoter methylation, and NtAI. Association between BRCA1 transcript level.
Number of identical D-loop DNA clones detected in 10 DNA clones derived from liver tumor tissues. Number of identical D-loop DNA clones detected in 10.
CREBBP loss-of-function results in gene expression repression signature. CREBBP loss-of-function results in gene expression repression signature. A–D,
Structures of wild-type and mutated recombinant CDX2.
Clustering analysis of DTC-associated genes.
Possible outcomes of therapeutic treatments using the spiral model.
Ten most frequent TCRs in the bulk 12TILs comprise >99% of the TIL population, and the neoantigens are shown to be the most dominant clones. Ten most frequent.
Frequently mutated genes in colorectal cancer.
Molecular definitions of lung adenocarcinoma subtypes.
Concordance between the genomic landscape identified by whole-exome sequencing of plasma cfDNA and tumor; DNA and recurrence of KDR/VEGFR2 oncogenic mutations.
Predicted pathogenic BRCA1 amino acid substitutions are confined to the evolutionarily conserved N- and C-terminal domains. Predicted pathogenic BRCA1.
A, Schematic diagram of identified splice variants of PD-L1.
Landscape of genomic alterations identified by WES in biopsies of patients with advanced PDAC. Co-mutation plot displaying integrated genomic data for.
LUBAC is essential for NF-κB activity in ABC DLBCL
Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.
Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy. Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy.
Core melanoma escape pathways during disease progression on BRAF inhibitor therapy. Core melanoma escape pathways during disease progression on BRAF inhibitor.
High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies. High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies.
A, study design for measuring the feasibility, concordance, and accuracy of a plasma-based cfDNA sequencing test compared with biopsy-based sequencing.
Driver pathways and key genes in OSCC
Curative effect of W+T treatment in vivo.
CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.
Integrated analysis of gene expression and copy number alterations.
Comparison of PD-L1 mAbs in IHC across multiple tumor types.
MITF-low/NF-κB–high transcriptional class is present and associated with resistance to MAPK pathway inhibition in human tumors. MITF-low/NF-κB–high transcriptional.
Alignment of the Amino Acid Sequences of NCS and Other PR10/Bet v1 Proteins from Various Plant Species.Deduced amino acid sequences were aligned using.
Presentation transcript:

Enrichment of two rare SNPs among ABC DLBCL tumors. Enrichment of two rare SNPs among ABC DLBCL tumors. A, amino acid sequence (based on accession NP_060469) of a region of the UBA domain of RNF31 showing the residues altered by two SNPs, Q584H and Q622L, and the number and type of lymphoma biopsies in which they were identified. B, location of the residues altered by the RNF31 SNPs in two views of the three-dimensional structure of the RNF31 UBA domain. C, frequencies of RNF31 SNPs in biopsy samples from different lymphoma subtypes. Yibin Yang et al. Cancer Discovery 2014;4:480-493 ©2014 by American Association for Cancer Research